OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
Just days earlier, on December 23, Lake Street analyst Eric Martinuzzi also reiterated a Buy rating on the stock, setting a $24 price target. everything possible/Shutterstock.com On December 17, OptimizeRx Corp (NASDAQ:OPRX) revealed a major expansion of its point-of-care network, which it said is aimed at boosting reach and engagement in clinical workflows. The move involves four new agreements: first, an exclusive multi-year deal with a sought-after e-prescribing platform. OptimizeRx stated that this platform was once exclusive to a rival network, and bringing it into its fold widens access during prescription processes. Second, a fresh partnership introduces coverage in the point-of-discharge phase. This will allow interactions with providers right as patient treatment plans and instructions are set. OptimizeRx sees this as an opportunity to extend its presence beyond traditional settings. Third and fourth, there will be multi-year renewals with two top-performing electroni
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Q4 2025 Earnings Preview [Seeking Alpha]Seeking Alpha
- OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ETGlobeNewswire
- OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare MarketingGlobeNewswire
- OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story [Seeking Alpha]Seeking Alpha
- OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
OPRX
Earnings
- 11/6/25 - Beat
OPRX
Sec Filings
- 2/13/26 - Form 4
- 12/23/25 - Form 4/A
- 12/23/25 - Form 4
- OPRX's page on the SEC website